The involvement of ADAR1 in antidepressant action by regulating BDNF via miR-432

Xiaonan Zhang,Ying Xue,Jinying Li,Hong Xu,Wei Yan,Ziwei Zhao,Weizhi Yu,Xiuli Zhai,Ye Sun,Yi Wu,Yufei Li,Lin Gui,Deqin Yu,Zhaoyang Xiao,Shengming Yin
DOI: https://doi.org/10.1016/j.bbr.2020.113087
IF: 3.352
2021-03-01
Behavioural Brain Research
Abstract:<p>Brain-derived neurotrophic factor (BDNF) is a biomarker of depression. Recent studies have found adenosine deaminase acting on RNA1 (ADAR1) is a novel target being sensitive to stress at epigenetic level. The epigenetic regulation mechanism of stress-related depression is still unclear so far. To explore the potential regulating mechanism of ADAR1 on BDNF, over and low expression of ADAR1 in PC12 and SH-SY5Y cell lines are prepared. In the meanwhile, chronic unpredictable stress (CUS) mice are treated with ADAR1 inducer (interferon-γ, IFN-γ). ADAR1 regulates BDNF expression, which is proven by that over and low expressions of ADAR1 increase and decrease BDNF mRNA and protein respectively in vitro. Additionally, ADAR1 inducer alleviates the depressive-like behavior of CUS mice by recovering the decreased BDNF protein in brain and serum. Moreover, over and low expressions of ADAR1 reduce and enhance microRNA-432 (miR-432) expression respectively in vitro. Furtherly, over and low miR-432 expressions lead to decreased and increased BDNF and ADAR1 mRNA, protein and immunoreactivity respectively in vitro. The above results demonstrate that ADAR1 is involved in antidepressant action by regulating BDNF via miR-432. Those novel findings can provide a new idea for the study of epigenetic regulation mechanism, early diagnosis, and effective treatment of stress-related depression.</p>
behavioral sciences,neurosciences
What problem does this paper attempt to address?